Health ❯Mental Health ❯PTSD

MDMA

Therapy Treatment Research Risks FDA Evaluation Clinical Trials

FDA Declines MDMA for PTSD Treatment, Requests Further Trials

The decision marks the first time the agency has considered a Schedule I psychedelic for medical use, highlighting ethical and safety concerns.

FDA Panel Rejects MDMA for PTSD Treatment Over Data Concerns

FDA Reviews MDMA-Assisted Therapy for PTSD as Congress Pushes Psychedelic Research